Pennsylvania SB 1055: An Act amending the act of September 27, 1961 (P.L.1700, No.699), known as the Pharmacy Act, further providing for pharmacy technician and pharmacy technician trainee registration, qualifications and supervision; providing for administration of injectable medications, biologicals and immunizations, for clinical laboratory certificate and for report on pharmacy-administered vaccines; and making a repeal.

Bill Text

PRINTER'S NO. 1247
THE GENERAL ASSEMBLY OF PENNSYLVANIA
SENATE BILL
No. 1055
Session of
2025
INTRODUCED BY COLLETT, PISCIOTTANO, KEARNEY, TARTAGLIONE,
HAYWOOD, KANE, SANTARSIERO, COSTA, L. WILLIAMS, CAPPELLETTI,
VOGEL AND SAVAL, OCTOBER 17, 2025
REFERRED TO CONSUMER PROTECTION AND PROFESSIONAL LICENSURE,
OCTOBER 17, 2025
AN ACT
Amending the act of September 27, 1961 (P.L.1700, No.699),
entitled "An act relating to the regulation of the practice
of pharmacy, including the sales, use and distribution of
drugs and devices at retail; and amending, revising,
consolidating and repealing certain laws relating thereto,"
further providing for pharmacy technician and pharmacy
technician trainee registration, qualifications and
supervision; providing for administration of injectable
medications, biologicals and immunizations, for clinical
laboratory certificate and for report on pharmacy-
administered vaccines; and making a repeal.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Section 3.3(a)(4) of the act of September 27,
1961 (P.L.1700, No.699), known as the Pharmacy Act, is amended
to read:
Section 3.3. Pharmacy Technician and Pharmacy Technician
Trainee Registration, Qualifications and Supervision.--(a) A
pharmacy technician shall register with the board biennially on
a form prescribed by the board and pay a registration fee
established by the board by regulation. An individual must
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21

possess an unrestricted registration from the board to practice
as a pharmacy technician. The following shall apply:
* * *
(4) An individual practicing as a pharmacy technician for at
least one year [of] between January 29, 2019, and June 28, 2025,
within the two-year period immediately preceding the [effective
date of this section] promulgation of final-form regulations by
the board implementing this section shall not be required to
comply with clause (3)(i) or (ii), provided the individual
applies within one year of the promulgation of regulations by
the board implementing this section.
* * *
Section 2. The act is amended by adding sections to read:
Section 3.5. Administration of Injectable Medications,
Biologicals and Immunizations.--(a) The board shall by
regulation establish education and training standards and
practice guidelines pursuant to which pharmacists shall be
authorized to administer injectable medications, biologicals and
immunizations to individuals eight years of age or older and
influenza and COVID-19 immunizations by injectable or needle-
free delivery methods to individuals five years of age or older.
The standards and guidelines shall include the following:
(1) Satisfactory completion of an academic and practical
curriculum approved by the board that includes the current
guidelines and recommendations of the Centers for Disease
Control and Prevention in the Public Health Service of the
United States Department of Health and Human Services, the
American Council on Pharmaceutical Education or a similar health
authority or professional body and includes disease
epidemiology, vaccine characteristics, injection technique,
20250SB1055PN1247 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

emergency response to adverse events and related topics.
(2) Maintenance of a current cardiopulmonary resuscitation
certificate acceptable to the board.
(3) That the administration of injectable medications,
biologicals and immunizations be in accordance with a definitive
set of treatment guidelines established by a physician and
consistent with one of the following:
(i) The Centers for Disease Control and Prevention's
Advisory Committee on Immunization Practices recommendations or
another competent authority approved by the board.
(ii) A determination by the Department of Health that both
of the following apply:
(A) Immunization of a population or subpopulation is
supported by medical evidence.
(B) Immunization of the population or subpopulation would
advance the public health by reducing the spread or severity of
infectious disease in this Commonwealth.
(4) The Department of Health may exclude an immunization
from a determination under clause (3)(ii) upon finding that all
of the following apply:
(i) Administration is no longer supported by medical
evidence for a population or subpopulation.
(ii) Administration is no longer effective to reduce the
spread or severity of infectious diseases in this Commonwealth
and would not advance the public health.
(5) In making a determination under paragraph (3) or (4),
the Department of Health may consider as evidence reports issued
by any of the following:
(i) The American Academy of Pediatrics.
(ii) The American College of Obstetricians and
20250SB1055PN1247 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Gynecologists.
(iii) The American College of Physicians.
(iv) The American Academy of Family Physicians.
(v) The I